We are live on ! Find out more
ELV icon

Elevance Health

396.58 USD
-2.53
0.63%
At close Updated Aug 28, 10:00 AM EDT
1 day
-0.63%
5 days
-1.14%
1 month
2.81%
3 months
0.98%
6 months
34.86%
Year to date
11.95%
1 year
27.76%
5 years
7.02%
10 years
219.36%
 

About: Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Employees: 97,100

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 47.7%
Neutral 45.5%
Negative 6.8%
Positive
Zacks Investment Research
2 days ago
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
Negative
Seeking Alpha
10 days ago
U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership
Most leading US publicly traded managed care insurers raised their full-year earnings estimates following second quarter results, despite increasing medical costs and membership attrition. Many of the top publicly traded US managed care insurers' medical costs rose in the second quarter of 2026, following notable increases throughout 2025.
U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership
Positive
Zacks Investment Research
13 days ago
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?
Neutral
Seeking Alpha
15 days ago
Diamond Hill Large Cap Fund Q2 2026 Portfolio Update
Key contributors include Texas Instruments, Humana, and Nucor. Key detractors include Zoetis, ConocoPhillips, and Accenture. New positions include Elevance Health, FedEx Freight, and Humana.
Diamond Hill Large Cap Fund Q2 2026 Portfolio Update
Neutral
Business Wire
28 days ago
Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
INDIANAPOLIS--(BUSINESS WIRE)--Cancer care is often overwhelming, not just medically, but emotionally and logistically. Elevance Health is strengthening its connected cancer care model to enhance support consumers receive throughout their care journeys, with a focus on earlier support, personalized care navigation, and more coordinated care.Each year in the U.S., 1.8 million people are diagnosed with cancer. For many patients, a cancer diagnosis brings not only medical decisions, but also a comp.
Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
Neutral
Seeking Alpha
29 days ago
Oakmark U.S. Large Value Strategy Q2 2026 Portfolio Review
Delta Air Lines was a contributor during the quarter. Fuel prices spiked in March following the onset of the Iran War, creating a near-term headwind for airline profitability. Intercontinental Exchange stock price declined due to market concerns about AI disruption and potential competition from new exchanges launching perpetual futures. We were pleased to initiate a position in Equitable Holdings at a meaningful discount to intrinsic value.
Oakmark U.S. Large Value Strategy Q2 2026 Portfolio Review
Neutral
Seeking Alpha
1 month ago
GreensKeeper Value Fund Q2 2026 Portfolio Update
Our top performer in the second quarter was ICON plc, which gained 57%. Our largest detractor during the quarter was Intercontinental Exchange, which declined 21.7%. We made no major changes to the portfolio during the quarter.
GreensKeeper Value Fund Q2 2026 Portfolio Update
Neutral
24/7 Wall Street
1 month ago
Billionaire Investor Seth Klarman's Top 5 Stocks: Would He Buy More Today?
Seth Klarman's Baupost Group rarely shows its cards, so when the latest 13F filing (holdings as of March 31, 2026, filed May 14, 2026) disclosed his five largest long common-stock positions, the disclosure read like a treasure map.
Billionaire Investor Seth Klarman's Top 5 Stocks: Would He Buy More Today?
Neutral
Seeking Alpha
1 month ago
Artisan Value Fund Q2 2026 Portfolio Update
US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investment. Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Our top five contributors to return in Q2 were Texas Instruments, Lam Research, NXP Semiconductors, Elevance Health and Alphabet.
Artisan Value Fund Q2 2026 Portfolio Update
Positive
The Motley Fool
1 month ago
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?
The purchase of 1,000 shares at $366.05 per share represents a total capital commitment of $366,050. This transaction increased the director's total direct equity position by 10% relative to his pre-trade holdings.
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?
Price charts implemented using Lightweight Charts™